Popular back pain medication linked to brain health risks in some patients

A painkiller used for lower back pain could be linked to a higher peril of dementia and mild cognitive impairment MCI according to new research The assessment published online in the journal Regional Anesthesia Pain Medicine determined that groups previously considered too young to develop the conditions faced more than twice the vulnerability when taking gabapentin Our findings indicate an association between gabapentin prescription and dementia or cognitive impairment within years the research unit stated in a press release BREAST CANCER SURVIVORS MAY HAVE LOWER LIABILITY OF EMERGING ALZHEIMER'S CONDITION ANALYSIS FINDSThe drug has become increasingly popular for treating chronic pain especially neuropathic nerve pain the researchers noted in a press release Gabapentin which is also used to control seizures according to Cleveland Clinic has relatively low addictive possible compared to traditional opioids Latest research has sparked new concerns over its side effects including a achievable association with neurodegeneration Previous findings could not confirm a specific link especially regarding whether certain age groups are more vulnerable In the latest research researchers collected evidence from TriNetX a fitness research infrastructure containing electronic physical condition records from healthcare organizations across the U S MORE SENIORS ARE USING CANNABIS THAN EVER BEFORE DESPITE SOUNDNESS RISKS RESEARCH SHOWSExamining anonymous records of adult patients the unit looked at groups who had been prescribed gabapentin for chronic lower back pain between and and compared them to people who hadn t received the drug There were a total of individuals in each group The researchers accounted for factors like demographics co-existing conditions and the use of other pain-relieving drugs Patients who had received six or more gabapentin prescriptions were more likely to be diagnosed with dementia and more likely to be diagnosed with MCI within years of their initial pain evaluation the evaluation exposed Looking at specific age groups people between and years old who received the drug were more than twice as likely to develop either condition than those who hadn t been prescribed gabapentin CLICK HERE TO SIGN UP FOR OUR VITALITY NEWSLETTERWhile there was no heightened jeopardy among those aged to who were prescribed the drug the jeopardy of dementia more than doubled and the exposure of MCI more than tripled among - to -year-olds Researchers observed a similar pattern among - to -year-olds Risks rose with prescription frequency Patients with or more prescriptions were more likely to develop dementia and more likely to develop MCI than those who were prescribed gabapentin between three and times The survey did have specific limitations As this was an observational examination no firm conclusions can be drawn about cause and effect the researchers noted For more Soundness articles visit www foxnews com healthThey also acknowledged that because the assessment was retrospective they couldn t account for dose or length of gabapentin use The results encouragement the need for close monitoring of adult patients prescribed gabapentin to assess for feasible cognitive decline the researchers added